{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:38:16Z","timestamp":1792787896180,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Science and Technology Council, Taiwan","award":["NSTC 113-2314-B-242 -002"],"award-info":[{"award-number":["NSTC 113-2314-B-242 -002"]}],"id":[{"id":"https:\/\/ror.org\/02kv4zf79","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Fooyin University Foundation, Taiwan","award":["FYU-1300-114-04"],"award-info":[{"award-number":["FYU-1300-114-04"]}],"id":[{"id":"https:\/\/ror.org\/03pfmgq50","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurosci"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Short-chain fatty acids regulate intestinal homeostasis and modulate the gut\u2013brain axis, suggesting they may be applicable in adjunctive treatments for Parkinson\u2019s disease (PD). However, the therapeutic efficacy of sodium butyrate (NaB) in PD remains unclear. Using appropriate PD animal models may aid in clarifying the therapeutic effects of NaB and facilitate the development of NaB-based PD treatment strategies. We comprehensively evaluated the therapeutic effects of oral NaB in rats with 6-hydroxydopamine (6-OHDA)-induced PD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We induced hemiparkinsonism in rats by administering unilateral 6-OHDA in the medial forebrain bundle. At 24\u00a0h after confirming lesion development, some rats were randomized to receive oral NaB (administered daily) over 4 weeks. Behavioral assessments\u2014comprising gait analysis, open-field activity, and apomorphine-induced rotations\u2014were performed longitudinally in weeks 1 and 4. Finally, dopaminergic neuronal degeneration was evaluated to correlate functional recovery with structural neuroprotection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The 4-week oral NaB intervention significantly alleviated 6-OHDA-induced motor deficits (i.e., locomotor activity, akinesia, and gait) and anxiety-like behavior; however, it did not alleviate apomorphine-induced rotations. Tyrosine hydroxylase immunohistochemical staining confirmed these findings, indicating that the dopaminergic neuron survival rate was significantly higher in the NaB-treated groups than in the sham control group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Early long-term oral NaB treatment afforded neuroprotection and alleviated motor and non-motor deficits (such as gait and central time in the open field) in rats with 6-OHDA-induced PD. Our model indicates the therapeutic potential of oral NaB and provides a translational framework for investigating the mechanisms of NaB therapy in PD and associated neurological disorders.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12868-026-01046-x","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T09:44:14Z","timestamp":1788947054000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Oral sodium butyrate alleviates motor deficits and dopaminergic neuronal loss in 6-hydroxydopamine-induced Parkinson\u2019s disease rat model"],"prefix":"10.1186","volume":"27","author":[{"given":"Shun-Tai","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang-Ching","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Jen","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Wei","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Lu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Yu","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsien-Yu","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2667-1174","authenticated-orcid":false,"given":"Wan-Ling","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"issue":"3","key":"1046_CR1","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.brs.2020.02.002","volume":"13","author":"XJ Feng","year":"2020","unstructured":"Feng XJ, Huang YT, Huang YZ, Kuo CW, Peng CW, Rotenberg A, et al. Early transcranial direct current stimulation treatment exerts neuroprotective effects on 6-OHDA-induced Parkinsonism in rats. Brain Stimul. 2020;13(3):655\u201363.","journal-title":"Brain Stimul"},{"key":"1046_CR2","doi-asserted-by":"publisher","first-page":"1763533","DOI":"10.1155\/2021\/1763533","volume":"2021","author":"TH Hsieh","year":"2021","unstructured":"Hsieh TH, He XK, Liu HH, Chen JJ, Peng CW, Liu HL, et al. Early Repetitive Transcranial Magnetic Stimulation Exerts Neuroprotective Effects and Improves Motor Functions in Hemiparkinsonian Rats. Neural Plast. 2021;2021:1763533.","journal-title":"Neural Plast"},{"key":"1046_CR3","doi-asserted-by":"publisher","first-page":"120166","DOI":"10.1016\/j.jns.2022.120166","volume":"434","author":"RJ Solch","year":"2022","unstructured":"Solch RJ, Aigbogun JO, Voyiadjis AG, Talkington GM, Darensbourg RM, O\u2019Connell S, et al. Mediterranean diet adherence, gut microbiota, and Alzheimer\u2019s or Parkinson\u2019s disease risk: A systematic review. J Neurol Sci. 2022;434:120166.","journal-title":"J Neurol Sci"},{"issue":"Suppl 1","key":"1046_CR4","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/jnc.13691","volume":"139","author":"S Sveinbjornsdottir","year":"2016","unstructured":"Sveinbjornsdottir S. The clinical symptoms of Parkinson\u2019s disease. J Neurochem. 2016;139(Suppl 1):318\u201324.","journal-title":"J Neurochem"},{"issue":"7","key":"1046_CR5","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1024\/1661-8157\/a002306","volume":"105","author":"JC M\u00f6ller","year":"2016","unstructured":"M\u00f6ller JC, Menig A, Oechsner M. [Neurorehabilitation in Parkinson\u2019s disease]. Praxis (Bern 1994). 2016;105(7):377\u201382.","journal-title":"Praxis (Bern 1994)"},{"issue":"9996","key":"1046_CR6","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE. Parkinson\u2019s disease. Lancet. 2015;386(9996):896\u2013912.","journal-title":"Lancet"},{"key":"1046_CR7","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.pneurobio.2015.07.002","volume":"132","author":"MF Bastide","year":"2015","unstructured":"Bastide MF, Meissner WG, Picconi B, Fasano S, Fernagut PO, Feyder M, et al. Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson\u2019s disease. Prog Neurobiol. 2015;132:96\u2013168.","journal-title":"Prog Neurobiol"},{"issue":"16","key":"1046_CR8","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1001\/jama.2014.3654","volume":"311","author":"BS Connolly","year":"2014","unstructured":"Connolly BS, Lang AE. Pharmacological treatment of Parkinson disease: a review. JAMA. 2014;311(16):1670\u201383.","journal-title":"JAMA"},{"issue":"6","key":"1046_CR9","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/ana.25364","volume":"84","author":"AJ Espay","year":"2018","unstructured":"Espay AJ, Morgante F, Merola A, Fasano A, Marsili L, Fox SH, et al. Levodopa-induced dyskinesia in Parkinson disease: Current and evolving concepts. Ann Neurol. 2018;84(6):797\u2013811.","journal-title":"Ann Neurol"},{"issue":"11 Suppl 4","key":"1046_CR10","first-page":"S13","volume":"55","author":"JA Obeso","year":"2000","unstructured":"Obeso JA, Rodriguez-Oroz MC, Chana P, Lera G, Rodriguez M, Olanow CW. The evolution and origin of motor complications in Parkinson\u2019s disease. Neurology. 2000;55(11 Suppl 4):S13\u201320. discussion S1\u20133.","journal-title":"Neurology"},{"key":"1046_CR11","doi-asserted-by":"publisher","first-page":"127858","DOI":"10.1016\/j.micres.2024.127858","volume":"287","author":"S Qu","year":"2024","unstructured":"Qu S, Yu Z, Zhou Y, Wang S, Jia M, Chen T, et al. Gut microbiota modulates neurotransmitter and gut-brain signaling. Microbiol Res. 2024;287:127858.","journal-title":"Microbiol Res"},{"key":"1046_CR12","doi-asserted-by":"publisher","first-page":"107988","DOI":"10.1016\/j.pharmthera.2021.107988","volume":"231","author":"SB Chidambaram","year":"2022","unstructured":"Chidambaram SB, Essa MM, Rathipriya AG, Bishir M, Ray B, Mahalakshmi AM, et al. Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: Tales of a vicious cycle. Pharmacol Ther. 2022;231:107988.","journal-title":"Pharmacol Ther"},{"issue":"5","key":"1046_CR13","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1007\/s11011-024-01369-w","volume":"39","author":"JP Fabi","year":"2024","unstructured":"Fabi JP. The connection between gut microbiota and its metabolites with neurodegenerative diseases in humans. Metab Brain Dis. 2024;39(5):967\u201384.","journal-title":"Metab Brain Dis"},{"issue":"10","key":"1046_CR14","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1093\/brain\/awaa238","volume":"143","author":"J Horsager","year":"2020","unstructured":"Horsager J, Andersen KB, Knudsen K, Skj\u00e6rb\u00e6k C, Fedorova TD, Okkels N, et al. Brain-first versus body-first Parkinson\u2019s disease: a multimodal imaging case-control study. Brain. 2020;143(10):3077\u201388.","journal-title":"Brain"},{"issue":"11","key":"1046_CR15","doi-asserted-by":"publisher","first-page":"3557","DOI":"10.1111\/ene.15767","volume":"30","author":"S Kundu","year":"2023","unstructured":"Kundu S, Nayak S, Rakshit D, Singh T, Shukla R, Khatri DK, et al. The microbiome-gut-brain axis in epilepsy: pharmacotherapeutic target from bench evidence for potential bedside applications. Eur J Neurol. 2023;30(11):3557\u201367.","journal-title":"Eur J Neurol"},{"key":"1046_CR16","doi-asserted-by":"publisher","first-page":"114081","DOI":"10.1016\/j.bbr.2022.114081","volume":"436","author":"D Rathour","year":"2023","unstructured":"Rathour D, Shah S, Khan S, Singh PK, Srivastava S, Singh SB, et al. Role of gut microbiota in depression: Understanding molecular pathways, recent research, and future direction. Behav Brain Res. 2023;436:114081.","journal-title":"Behav Brain Res"},{"issue":"1","key":"1046_CR17","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s12264-025-01498-x","volume":"42","author":"AE Abreu","year":"2026","unstructured":"Abreu AE, Empadinhas N, Cardoso SM. Unveiling Butyrate as a Parkinson\u2019s Disease Therapy. Neurosci Bull. 2026;42(1):233\u201346.","journal-title":"Neurosci Bull"},{"issue":"4","key":"1046_CR18","doi-asserted-by":"publisher","first-page":"5169","DOI":"10.1007\/s12602-025-10796-9","volume":"18","author":"KS Pasupuleti","year":"2026","unstructured":"Pasupuleti KS, Yadav V, Baviskar K, Pradhan SM, Vora M. Natural and Biological Products Therapeutic Potential in Restoring Gut Microbiome: Mechanistic Insights and Clinical Implications. Probiotics Antimicrob Proteins. 2026;18(4):5169\u2013206.","journal-title":"Probiotics Antimicrob Proteins"},{"issue":"7","key":"1046_CR19","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1016\/j.clnu.2024.05.036","volume":"43","author":"AM Mincic","year":"2024","unstructured":"Mincic AM, Antal M, Filip L, Miere D. Modulation of gut microbiome in the treatment of neurodegenerative diseases: A systematic review. Clin Nutr. 2024;43(7):1832\u201349.","journal-title":"Clin Nutr"},{"key":"1046_CR20","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40478-015-0196-0","volume":"3","author":"T Clairembault","year":"2015","unstructured":"Clairembault T, Leclair-Visonneau L, Coron E, Bourreille A, Le Dily S, Vavasseur F, et al. Structural alterations of the intestinal epithelial barrier in Parkinson\u2019s disease. Acta Neuropathol Commun. 2015;3:12.","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"1046_CR21","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s44368-026-00029-8","volume":"3","author":"VS Jadhav","year":"2026","unstructured":"Jadhav VS, Nathiya D, Tomar BS, Khatri DK. Gut microbiome immune interactions drive neuroinflammation and neurodegeneration in Parkinson\u2019s disease. Discover Immun. 2026;3(1):10.","journal-title":"Discover Immun"},{"key":"1046_CR22","doi-asserted-by":"crossref","unstructured":"Li Q, Meng L-b, Chen L-j, Shi X, Tu L, Zhou Q et al. The role of the microbiota-gut-brain axis and intestinal microbiome dysregulation in Parkinson\u2019s disease. Front Neurol. 2023;14.","DOI":"10.3389\/fneur.2023.1185375"},{"issue":"6","key":"1046_CR23","first-page":"20","volume":"24","author":"C Armas","year":"2025","unstructured":"Armas C, Kaufman P, Gut-Brain, Axis. The Role of Gastrointestinal Issues in Parkinson\u2019s Disease. Integr Med (Encinitas). 2025;24(6):20\u20137.","journal-title":"Integr Med (Encinitas)"},{"issue":"8","key":"1046_CR24","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41575-019-0157-3","volume":"16","author":"B Dalile","year":"2019","unstructured":"Dalile B, Van Oudenhove L, Vervliet B, Verbeke K. The role of short-chain fatty acids in microbiota-gut-brain communication. Nat Rev Gastroenterol Hepatol. 2019;16(8):461\u201378.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1046_CR25","doi-asserted-by":"crossref","unstructured":"Begum N, Mandhare A, Tryphena KP, Srivastava S, Shaikh MF, Singh SB et al. Epigenetics in depression and gut-brain axis: a molecular crosstalk. Front Aging Neurosci. 2022;14","DOI":"10.3389\/fnagi.2022.1048333"},{"issue":"1","key":"1046_CR26","doi-asserted-by":"publisher","first-page":"2393270","DOI":"10.1080\/19490976.2024.2393270","volume":"16","author":"KE Hays","year":"2024","unstructured":"Hays KE, Pfaffinger JM, Ryznar R. The interplay between gut microbiota, short-chain fatty acids, and implications for host health and disease. Gut Microbes. 2024;16(1):2393270.","journal-title":"Gut Microbes"},{"key":"1046_CR27","doi-asserted-by":"publisher","first-page":"119186","DOI":"10.1016\/j.ecoenv.2025.119186","volume":"305","author":"L Xu","year":"2025","unstructured":"Xu L, Feng Z, Li Z, Qin S, Yang L, Xiao B, et al. Mechanism analysis of rotenone toxic exposure inducing neurotoxicity through the MAPK\/MMPs signaling pathway. Ecotoxicol Environ Saf. 2025;305:119186.","journal-title":"Ecotoxicol Environ Saf"},{"issue":"4","key":"1046_CR28","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1161\/CIRCRESAHA.119.316448","volume":"127","author":"J Lee","year":"2020","unstructured":"Lee J, d\u2019Aigle J, Atadja L, Quaicoe V, Honarpisheh P, Ganesh BP, et al. Gut Microbiota-Derived Short-Chain Fatty Acids Promote Poststroke Recovery in Aged Mice. Circ Res. 2020;127(4):453\u201365.","journal-title":"Circ Res"},{"issue":"3","key":"1046_CR29","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.yfrne.2014.02.002","volume":"35","author":"GE Gillies","year":"2014","unstructured":"Gillies GE, Pienaar IS, Vohra S, Qamhawi Z. Sex differences in Parkinson\u2019s disease. Front Neuroendocrinol. 2014;35(3):370\u201384.","journal-title":"Front Neuroendocrinol"},{"issue":"1","key":"1046_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbr.2011.03.031","volume":"222","author":"TH Hsieh","year":"2011","unstructured":"Hsieh TH, Chen JJ, Chen LH, Chiang PT, Lee HY. Time-course gait analysis of hemiparkinsonian rats following 6-hydroxydopamine lesion. Behav Brain Res. 2011;222(1):1\u20139.","journal-title":"Behav Brain Res"},{"issue":"7","key":"1046_CR31","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1093\/cercor\/bht421","volume":"25","author":"TH Hsieh","year":"2015","unstructured":"Hsieh TH, Huang YZ, Rotenberg A, Pascual-Leone A, Chiang YH, Wang JY, et al. Functional Dopaminergic Neurons in Substantia Nigra are Required for Transcranial Magnetic Stimulation-Induced Motor Plasticity. Cereb Cortex. 2015;25(7):1806\u201314.","journal-title":"Cereb Cortex"},{"issue":"9","key":"1046_CR32","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1007\/s11517-012-0933-5","volume":"50","author":"HY Lee","year":"2012","unstructured":"Lee HY, Hsieh TH, Liang JI, Yeh ML, Chen JJ. Quantitative video-based gait pattern analysis for hemiparkinsonian rats. Med Biol Eng Comput. 2012;50(9):937\u201346.","journal-title":"Med Biol Eng Comput"},{"key":"1046_CR33","volume-title":"The Rat Brain in Stereotaxic Coordinates","author":"G Paxinos","year":"2005","unstructured":"Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. Amsterdam: Elsevier Academic; 2005."},{"key":"1046_CR34","doi-asserted-by":"publisher","first-page":"108479","DOI":"10.1016\/j.envint.2024.108479","volume":"184","author":"Y Li","year":"2024","unstructured":"Li Y, Liu A, Chen K, Li L, Zhang X, Zou F, et al. Sodium butyrate alleviates lead-induced neuroinflammation and improves cognitive and memory impairment through the ACSS2\/H3K9ac\/BDNF pathway. Environ Int. 2024;184:108479.","journal-title":"Environ Int"},{"key":"1046_CR35","doi-asserted-by":"publisher","first-page":"4829572","DOI":"10.1155\/2019\/4829572","volume":"2019","author":"WL Tsai","year":"2019","unstructured":"Tsai WL, Chen HY, Huang YZ, Chen YH, Kuo CW, Chen KY, et al. Long-Term Voluntary Physical Exercise Exerts Neuroprotective Effects and Motor Disturbance Alleviation in a Rat Model of Parkinson\u2019s Disease. Behav Neurol. 2019;2019:4829572.","journal-title":"Behav Neurol"},{"issue":"4303","key":"1046_CR36","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1126\/science.877576","volume":"197","author":"I Creese","year":"1977","unstructured":"Creese I, Burt DR, Snyder SH. Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity. Science. 1977;197(4303):596\u20138.","journal-title":"Science"},{"issue":"1","key":"1046_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbr.2005.02.023","volume":"162","author":"R Iancu","year":"2005","unstructured":"Iancu R, Mohapel P, Brundin P, Paul G. Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson\u2019s disease in mice. Behav Brain Res. 2005;162(1):1\u201310.","journal-title":"Behav Brain Res"},{"issue":"3","key":"1046_CR38","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1111\/j.1460-9568.2005.04238.x","volume":"22","author":"GA Metz","year":"2005","unstructured":"Metz GA, Tse A, Ballermann M, Smith LK, Fouad K. The unilateral 6-OHDA rat model of Parkinson\u2019s disease revisited: an electromyographic and behavioural analysis. Eur J Neurosci. 2005;22(3):735\u201344.","journal-title":"Eur J Neurosci"},{"issue":"1","key":"1046_CR39","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.neulet.2007.06.031","volume":"423","author":"MC Yoon","year":"2007","unstructured":"Yoon MC, Shin MS, Kim TS, Kim BK, Ko IG, Sung YH, et al. Treadmill exercise suppresses nigrostriatal dopaminergic neuronal loss in 6-hydroxydopamine-induced Parkinson\u2019s rats. Neurosci Lett. 2007;423(1):12\u20137.","journal-title":"Neurosci Lett"},{"issue":"2","key":"1046_CR40","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/j.1460-9568.2006.05285.x","volume":"25","author":"F Blandini","year":"2007","unstructured":"Blandini F, Levandis G, Bazzini E, Nappi G, Armentero MT. Time-course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6-hydroxydopamine in the rat: new clues from an old model. Eur J Neurosci. 2007;25(2):397\u2013405.","journal-title":"Eur J Neurosci"},{"key":"1046_CR41","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.neulet.2016.04.049","volume":"622","author":"TP Silva","year":"2016","unstructured":"Silva TP, Poli A, Hara DB, Takahashi RN. Time course study of microglial and behavioral alterations induced by 6-hydroxydopamine in rats. Neurosci Lett. 2016;622:83\u20137.","journal-title":"Neurosci Lett"},{"issue":"2","key":"1046_CR42","first-page":"3356","volume":"17","author":"RJ Su","year":"2018","unstructured":"Su RJ, Zhen JL, Wang W, Zhang JL, Zheng Y, Wang XM. Time-course behavioral features are correlated with Parkinson\u2019s disease\u2013associated pathology in a 6-hydroxydopamine hemiparkinsonian rat model. Mol Med Rep. 2018;17(2):3356\u201363.","journal-title":"Mol Med Rep"},{"key":"1046_CR43","doi-asserted-by":"publisher","first-page":"848380","DOI":"10.3389\/fnagi.2022.848380","volume":"14","author":"CW Kuo","year":"2022","unstructured":"Kuo CW, Chang MY, Chou MY, Pan CY, Peng CW, Tseng HC, et al. Long-Term Motor Cortical Electrical Stimulation Ameliorates 6-Hydroxydopamine-Induced Motor Dysfunctions and Exerts Neuroprotective Effects in a Rat Model of Parkinson\u2019s Disease. Front Aging Neurosci. 2022;14:848380.","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"1046_CR44","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s10856-013-5036-9","volume":"25","author":"JI Liang","year":"2014","unstructured":"Liang JI, Lin PC, Chen MY, Hsieh TH, Chen JJ, Yeh ML. The effect of tenocyte\/hyaluronic acid therapy on the early recovery of healing Achilles tendon in rats. J Mater Sci Mater Med. 2014;25(1):217\u201327.","journal-title":"J Mater Sci Mater Med"},{"key":"1046_CR45","doi-asserted-by":"publisher","first-page":"12178","DOI":"10.1038\/srep12178","volume":"5","author":"H Li","year":"2015","unstructured":"Li H, Lei X, Yan T, Li H, Huang B, Li L, et al. The temporary and accumulated effects of transcranial direct current stimulation for the treatment of advanced Parkinson\u2019s disease monkeys. Sci Rep. 2015;5:12178.","journal-title":"Sci Rep"},{"key":"1046_CR46","doi-asserted-by":"crossref","unstructured":"Hsueh SC, Chen KY, Lai JH, Wu CC, Yu YW, Luo Y et al. Voluntary physical exercise improves subsequent motor and cognitive impairments in a rat model of parkinson\u2019s disease. Int J Mol Sci. 2018;19(2).","DOI":"10.3390\/ijms19020508"},{"issue":"1\u20133","key":"1046_CR47","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0014-2999(03)01272-X","volume":"463","author":"L Prut","year":"2003","unstructured":"Prut L, Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol. 2003;463(1\u20133):3\u201333.","journal-title":"Eur J Pharmacol"},{"key":"1046_CR48","doi-asserted-by":"crossref","unstructured":"Fock E, Parnova R. Mechanisms of blood-brain barrier protection by microbiota-derived short-chain fatty acids. Cells. 2023;12(4).","DOI":"10.3390\/cells12040657"},{"key":"1046_CR49","doi-asserted-by":"publisher","first-page":"1763305","DOI":"10.3389\/fimmu.2026.1763305","volume":"17","author":"J Lai","year":"2026","unstructured":"Lai J, Wang Y, Zeng L, Deng Q, Qiao Y, Liao J, et al. Melatonin alleviates airway inflammation and anxiety-depression in asthma via gut microbiota-SCFA axis-mediated inhibition of microglial activation. Front Immunol. 2026;17:1763305.","journal-title":"Front Immunol"},{"issue":"1\u20132","key":"1046_CR50","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/0006-8993(93)90576-9","volume":"626","author":"JL Hudson","year":"1993","unstructured":"Hudson JL, van Horne CG, Str\u00f6mberg I, Brock S, Clayton J, Masserano J, et al. Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats. Brain Res. 1993;626(1\u20132):167\u201374.","journal-title":"Brain Res"},{"key":"1046_CR51","doi-asserted-by":"publisher","first-page":"117345","DOI":"10.1016\/j.lfs.2020.117345","volume":"245","author":"YS Feng","year":"2020","unstructured":"Feng YS, Yang SD, Tan ZX, Wang MM, Xing Y, Dong F, et al. The benefits and mechanisms of exercise training for Parkinson\u2019s disease. Life Sci. 2020;245:117345.","journal-title":"Life Sci"}],"container-title":["BMC Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12868-026-01046-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12868-026-01046-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12868-026-01046-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T09:04:06Z","timestamp":1791363846000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12868-026-01046-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,9]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1046"],"URL":"https:\/\/doi.org\/10.1186\/s12868-026-01046-x","relation":{},"ISSN":["1471-2202"],"issn-type":[{"value":"1471-2202","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,9]]},"assertion":[{"value":"11 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This animal study was approved by the IACUC of Taipei Medical University (Approval No: SHLAC2024-0093, valid from October 1, 2024, to September 30, 2027).","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"43"}}